| Volume: | 1,423,682 |
|---|---|
| Day's Low: | $40.23 |
| 52-wk Low: | $27.45 |
| Previous Close: | $40.78 |
| Dividend: | $0.00 |
| Market Cap: | 5,037,000 |
| Avg Volume: | 1,152,100 |
|---|---|
| Day's High: | $41.34 |
| 52-wk High: | $42.50 |
| Open Price: | $40.83 |
| Yield: | 0.00% |
| P/E (Forward): | 12.74 |
| 8:03 AM | 3/4/2010 | Watson To Buy US Rights To Columbia Labs' Fertility Gels |
| 6:18 PM | 3/1/2010 | UPDATE: Watson Pharma To Sell ScinoPharm Taiwan Stake For $94 Million |
| 5:53 PM | 3/1/2010 | Watson Pharma To Sell 31% Stake In ScinoPharm Taiwan For $94 Million |
| 5:23 PM | 2/23/2010 | 2nd UPDATE: US Judge Ends FTC Challenge To AndroGel Pact |
| 4:01 PM | 2/23/2010 | UPDATE:US Judge Dismisses FTC Challenge To AndroGel Settlement |
| 2:02 PM | 2/23/2010 | CORRECT:US Judge Dismisses FTC Challenge To AndroGel Settlement |
| 3/10/2010 | Market-trouncing returns could be written in these five stars. (The Motley Fool) |
| 2/23/2010 | Updates, advisories and surprises (MarketWatch.com) |
| 1/21/2010 | Updates, advisories and surprises (MarketWatch.com) |
| 1/19/2010 | Serious, as in a potential $4-billion-purchase serious. (The Motley Fool) |
| 1/16/2010 | Preview (Barrons.com) |
| 12/22/2009 | It can pay to catch rising stars. (The Motley Fool) |
| 12/10/2009 | Drug stocks climb; Lilly falls on forecast (MarketWatch.com) |
| 12/1/2009 | Two stocks enter. One stock leaves. (The Motley Fool) |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.85 | 0.53 | 60.38 |
| EPS, GAAP | 0.51 | 0.49 | 4.08 |
| Consensus Estimate | 0.72 | 0.50 | 44.00 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 2.70 | 3.04 | -11.18 |
| EPS, GAAP | 1.95 | 2.09 | -6.70 |
| Consensus Estimate | 2.43 | NA | NA |
| WPI | Industry Average | |
| P/E (TTM) | 20.91 | 47.10 |
| P/E (Forward) | 12.74 | 2.70 |
| PEG Ratio | 1.41 | 0.13 |
| Price/Sales | 1.70 | 1.21 |
| Beta | 0.56 | 0.52 |